University President Ellen Granberg said Chief Financial Officer Bruno Fernandes renegotiated the MFA’s contract with Savista ...

From artificial intelligence to developments in robotic surgery, technology continues to reshape the ASC industry in new and dynamic ways.

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

At ViVE 2025, digital health leaders reveal new generative AI products and industry cost savings reports. Here's a look at ...

Healthcare organizations require thoughtful consideration of their data-input processes to avoid common, detrimental billing ...